( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
2827.41
3144.72
2841.37
2417.61
Total Expenditure
2864.63
2889.44
2593.7
2204.26
PBIDT (Excl OI)
-37.22
255.28
247.67
213.35
Other Income
51.7
69.61
59.42
52.31
Operating Profit
14.48
324.89
307.09
265.66
Exceptional Items
0.00
NA
NA
NA
PBDT
8.38
318.36
301.58
259.49
Depreciation
33.26
31.73
29.69
26.36
Profit Before Tax
-24.88
286.63
271.89
233.13
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-19.94
212.78
200.7
173.96
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-19.94
212.78
200.7
173.96
Minority Interest
2.86
1.42
-0.54
-0.16
Shares of Associates
-14.69
-23.35
-32.99
-18.56
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-31.77
190.85
167.17
155.24
Equity Capital
390.4
390.29
390.11
388.73
Calculated EPS
-0.08
0.48
0.42
0.39
Calculated EPS (Annualised)
-0.32
1.95
1.71
1.59
No of Public Share Holdings
390403607
390291963
390110629
388265878
% of Public Share Holdings
100
100
100
100
PBIDTM% (Excl OI)
-1.31
8.11
8.71
8.82
PBIDTM%
0.51
10.33
10.80
10.98
PBDTM%
0.29
10.12
10.61
10.73